Multiple Assemblies exist for SMTL entry 3r4p
Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide; X-RAY DIFFRACTION 1.70 Å

	SMTL ID 3r4p.1 Ligands 2-amino-4-{2,4-dichloro-6-[2-(1H-pyrazol-1-yl)ethoxy]phenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide; PHOSPHATE ION Polypeptides Heat shock protein HSP 90-alpha Oligo-state monomer
	SMTL ID 3r4p.2 Ligands 2-amino-4-{2,4-dichloro-6-[2-(1H-pyrazol-1-yl)ethoxy]phenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide Polypeptides Heat shock protein HSP 90-alpha Oligo-state monomer
	SMTL ID 3r4p.3 Ligands 2-amino-4-{2,4-dichloro-6-[2-(1H-pyrazol-1-yl)ethoxy]phenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide; PHOSPHATE ION Polypeptides Heat shock protein HSP 90-alpha Oligo-state homo-dimer